Press Releases

Date	Title
5/11/22	Pulse Biosciences Reports First Quarter 2022 Financial Results
5/4/22	Pulse Biosciences, Inc. Announces Commencement of Rights Offering
4/28/22	Pulse Biosciences Schedules First Quarter 2022 Financial Results Conference Call for May 11, 2022
4/26/22	Pulse Biosciences to Present New Data on Nano-Pulse Stimulation Procedure for Sebaceous Hyperplasia and for Focal Epithelial Hyperplasia at 2022 American Society of Laser Medicine and Surgery Annual Conference
4/14/22	Pulse Biosciences, Inc. Announces Rights Offering
3/31/22	Pulse Biosciences Reports Fourth Quarter & Full Year 2021 Financial Results
3/21/22	Pulse Biosciences Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call for March 31, 2022
2/15/22	Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer
2/8/22	Pulse Biosciences Provides an Update on Recent FDA 510(k) Submission
2/1/22	Pulse Biosciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Keyword Search